Pharma company planning major expansion in Shannon

The unit in the Shannon Free Zone business park will be used for the manufacture of MeiraGTx viral vectors for gene therapies and the plasmid DNA that is one of the starting materials in viral vector production. File picture: MeiraGTx
Biopharmaceutical company MeiraGTx is to significantly expand its manufacturing facility in Shannon.
The expanded facility will be designed for the manufacture of commercial-grade gene therapies. MeiraGTx is focused on developing potential treatments for patients living with serious diseases.